TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Unilever pursues GSK-Pfizer unit after huge bid rebuffed

(Agence France-Presse) (The Jakarta Post)
London
Tue, January 18, 2022 Published on Jan. 17, 2022 Published on 2022-01-17T22:17:07+07:00

Change text size

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Unilever pursues GSK-Pfizer unit after huge bid rebuffed

C

onsumer goods giant Unilever on Monday revealed ongoing interest in a consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer after a bid of 50 billion pounds (US$68 billion) was refused.

British group GSK said at the weekend that it had received three unsolicited offers from Unilever for GSK Consumer Healthcare but were rejected for being too low.

The unit's products include Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu.

"GSK Consumer Healthcare would be a strong strategic fit," British company Unilever said in a statement as it unveiled a strategy update in the wake of the weekend's takeover news.

"Unilever's future strategic direction lies in materially expanding its presence in health, beauty and hygiene," it said.

"These categories offer higher rates of sustainable market growth, with significant opportunities to drive growth through investment and innovation, and by leveraging Unilever's strong presence in emerging markets."

The latest bid was received on Dec. 20, 2021, for a total acquisition value of 50 billion pounds, comprising 41.7 billion pounds in cash and £8.3 billion in Unilever shares.

GSK owns a majority 68 percent of the unit with United States giant Pfizer the remainder.

"The board of GSK unanimously concluded that the proposals were not in the best interests of GSK shareholders as they fundamentally undervalued the consumer healthcare business and its future prospects," said a statement at the weekend.

The consumer healthcare business had annual sales of 9.6 billion pounds last year.

"As a result of the reporting of Unilever's interest in GSK Consumer Healthcare, we are today bringing forward a planned update, setting out the strategic direction that the company is pursuing," Unilever said.

In its strategic update, Unilever said "major acquisitions should be accompanied by the accelerated divestment of intrinsically lower growth brands and businesses. This would provide funding."

Purchase of the GSK-Pfizer unit "would create scale and a growth platform for the combined portfolio in the US, China and India, with further opportunities in other emerging markets", Unilever added.

Unilever in November 2021 agreed to sell its global tea business, including brands Lipton and PG Tips, for 4.5 billion euros ($5.14 billion).

Unilever, whose products include also Magnum ice cream, Cif surface cleaner and Dove soap, completed the merger of its Dutch and British corporate entities in 2020.

The group meanwhile recently posted rising sales thanks to price hikes.

The world is experiencing strong inflation as economies reopen from pandemic lockdowns amid supply constraints and strong demand.

Costs of raw materials and energy are surging, while a number of sectors are impacted additionally by a need to pay higher wages as they struggle to find staff.

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.

Share options

Quickly share this news with your network—keep everyone informed with just a single click!

Change text size options

Customize your reading experience by adjusting the text size to small, medium, or large—find what’s most comfortable for you.

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!

Continue in the app

Get the best experience—faster access, exclusive features, and a seamless way to stay updated.